MASP2 and cardiomyopathy: The frequency of the risk genotypes in both loci (COLEC11 AG+GG and MASP2*CD+ carriers) was higher in patients with cardiodigestive form (21%) and cardiomyopathy (13%), than healthy controls (2%), (p = 0.005, OR 15.2, 95% CI 1.7–137; p = 0.014, OR 9.3, 95% CI 1.2–74, respectively) (Table 6).